These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complications of HIV disease and antiretroviral therapy. Currier JS; Havlir DV Top HIV Med; 2009; 17(2):57-67. PubMed ID: 19401608 [TBL] [Abstract][Full Text] [Related]
4. Risk of cardiovascular disease in HIV-infected patients. Das S J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610 [TBL] [Abstract][Full Text] [Related]
5. Management of metabolic complications and cardiovascular risk in HIV-infected patients. Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187 [TBL] [Abstract][Full Text] [Related]
6. Optimal antiretroviral therapy for aging. Cordery DV; Cooper DA Sex Health; 2011 Dec; 8(4):534-40. PubMed ID: 22127040 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Disease and HIV Infection. Klein D; Hurley LB; Sidney S N Engl J Med; 2003 Nov; 349(19):1869-70; author reply 1869-70. PubMed ID: 14602888 [No Abstract] [Full Text] [Related]
8. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Deeks SG Top HIV Med; 2009; 17(4):118-23. PubMed ID: 19890183 [TBL] [Abstract][Full Text] [Related]
9. Secondary complications and co-infections in the HIV-infected adolescent in the antiretroviral era. Ross AC; Camacho-Gonzalez A; Chahroudi A; Chakraborty R Curr Opin Infect Dis; 2011 Jun; 24(3):212-8. PubMed ID: 21455061 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients. Fisher SD; Kanda BS; Miller TL; Lipshultz SE Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317 [TBL] [Abstract][Full Text] [Related]
11. Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy. Zhao H; Goetz MB J Antimicrob Chemother; 2011 Jun; 66(6):1210-4. PubMed ID: 21421583 [TBL] [Abstract][Full Text] [Related]
12. Management of antiretroviral treatment-related complications. Hoffman RM; Currier JS Infect Dis Clin North Am; 2007 Mar; 21(1):103-32, ix. PubMed ID: 17502232 [TBL] [Abstract][Full Text] [Related]
14. Endothelial function in HIV-infected patients with low or mild cardiovascular risk. Blanco JJ; García IS; Cerezo JG; de Rivera JM; Anaya PM; Raya PG; García JG; López JR; Hernández FJ; Rodríguez JJ J Antimicrob Chemother; 2006 Jul; 58(1):133-9. PubMed ID: 16702174 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and HIV infection: host, virus, or drugs? Martínez E; Larrousse M; Gatell JM Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078 [TBL] [Abstract][Full Text] [Related]
16. HIV infection and aging of the innate immune system. Hearps AC; Angelovich TA; Jaworowski A; Mills J; Landay AL; Crowe SM Sex Health; 2011 Dec; 8(4):453-64. PubMed ID: 22127030 [TBL] [Abstract][Full Text] [Related]
17. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment. Crook M Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292 [TBL] [Abstract][Full Text] [Related]
18. HIV infection, aging and cardiovascular disease: epidemiology and prevention. Petoumenos K; Worm SW Sex Health; 2011 Dec; 8(4):465-73. PubMed ID: 22127031 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus. Magen E; Elbirt D; Sthoeger Z Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207 [TBL] [Abstract][Full Text] [Related]
20. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment. Steinhart CR; Emons MF AIDS Read; 2004 Feb; 14(2):86-90, 93-5. PubMed ID: 14997864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]